German pharmaceuticals giant Bayer has agreed to buy American GMO company Monsanto for $128 a share. The acquisition values Monsanto’s equity at about $56 billion, but including debt the deal is worth nearly $66 billion….
The Best in Alternative News
at
German pharmaceuticals giant Bayer has agreed to buy American GMO company Monsanto for $128 a share. The acquisition values Monsanto’s equity at about $56 billion, but including debt the deal is worth nearly $66 billion….
Any publication posted at The T-Room and/or opinions expressed therein do not necessarily reflect the views of The T-Room. Such publications and all information within the publications (e.g. titles, dates, statistics, conclusions, sources, opinions, etc) are solely the responsibility of the author of the article, not The T-Room.